FDA Inspection 1215028 — Refine USA, LLC

Refine USA, LLC — FEI 3006033709

The FDA completed an inspection of Refine USA, LLC on August 16, 2023 in Jacksonville, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 1 citation was issued during this inspection. Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 16, 2023
Fiscal Year
2023
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Jacksonville, FL (United States)

Citations

IDCFRDescription
47921 CFR 820.50Purchasing controls, Lack of or inadequate procedures